CERTA Therapeutics
Founded 2018 · 8 employees on LinkedIn · 3 known investors
Find your way into CERTA Therapeutics
Sign up to see every warm intro you have to CERTA Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CERTA Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Certa Therapeutics develops targeted therapeutics to treat fibrotic diseases including scleroderma, chronic kidney disease, diabetic nephropathy, and focal segmental glomerulosclerosis. The company serves patients with serious, often life-threatening fibrotic conditions.
Investors · 3
Brandon Capital Partnerslisted by Brandon Capital PartnersMelbourne
How we know: Brandon Capital Partners's portfolio page · Not right? Tell us
Stoic VClisted by Stoic VCSydney · $65K – $650K
How we know: Stoic VC's portfolio page · Not right? Tell us
UniSeed Pty Ltd.listed by UniSeed Pty Ltd.Brisbane · $165K – $330K
How we know: UniSeed Pty Ltd.'s portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does CERTA Therapeutics do?
- Certa Therapeutics develops targeted therapeutics to treat fibrotic diseases including scleroderma, chronic kidney disease, diabetic nephropathy, and focal segmental glomerulosclerosis. The company serves patients with serious, often life-threatening fibrotic conditions.
- Who are CERTA Therapeutics's investors?
- CERTA Therapeutics's investors include Brandon Capital Partners, Stoic VC, UniSeed Pty Ltd..



